SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-20-000014
Filing Date
2020-05-11
Accepted
2020-05-11 17:09:05
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q egrxq120202.htm   iXBRL 10-Q 1212266
2 EXHIBIT 10.2 TYME CO-PROMOTE exhibit102tyme-eagleco.htm EX-10.2 423227
3 EXHIBIT 31.1 exhibit311q120202.htm EX-31.1 9708
4 EXHIBIT 31.2 exhibit312q120202.htm EX-31.2 9671
5 EXHIBIT 32.1 exhibit321q120202.htm EX-32.1 10023
11 exhibit10tymeeaglecop_image1.gif GRAPHIC 7579
12 exhibit10tymeeaglecop_image2.gif GRAPHIC 4125
  Complete submission text file 0000827871-20-000014.txt   6704582

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20200331.xsd EX-101.SCH 40421
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20200331_cal.xml EX-101.CAL 102860
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20200331_def.xml EX-101.DEF 171987
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20200331_lab.xml EX-101.LAB 587674
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20200331_pre.xml EX-101.PRE 339724
22 EXTRACTED XBRL INSTANCE DOCUMENT egrxq120202_htm.xml XML 1049444
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 20865954
SIC: 2834 Pharmaceutical Preparations